Natural History of Human Epidermal Growth Factor Receptor 2-Amplified and Human Epidermal Growth Factor Receptor 2 Wild-Type Refractory Metastatic Colorectal Cancer in US Clinical Practice (vol 6, e2100133, 2022)

被引：0
|
作者：
Schroder, Carsten
Gower-Page, Craig
Reyes-Rivera, Irmarie
Patel, Arisha
Price, Richard
Sen, Shiraj
Davies, Jessica
Castellanos, Emily
Snider, Jeremy
Bai, Xiaobo
Fisher, Virginia
Mhatre, Shivani K.
机构：
来源：
JCO CLINICAL CANCER INFORMATICS | 2022年 / 6卷 / 01期
关键词：
D O I：
10.1200/CCI.22.00042
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Targeting the Human Epidermal Growth Factor Receptor 2 in Esophageal Cancer
    Almhanna, Khaldoun
    Meredith, Kenneth L.
    Hoffe, Sarah E.
    Shridhar, Ravi
    Coppola, Domenico
    CANCER CONTROL, 2013, 20 (02) : 111 - 116
  • [22] Effect of human epidermal growth factor receptor 2 overexpression in metastatic colorectal cancer on standard chemotherapy outcomes
    Jang, Jae Yeon
    Jeon, Young Kyung
    Jeong, Sun Young
    Lim, Sung Hee
    Park, Young Suk
    Lim, Ho Yeong
    Lee, Jee Yun
    Kim, Seung Tae
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 14 (05) : 2097 - 2110
  • [23] Targeting human epidermal growth factor receptor 2: It is time to kill kinase death human epidermal growth factor receptor 3
    Menendez, Javier A.
    Lupu, Ruth
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (17) : 2496 - 2498
  • [24] INHERENT RESISTANCE IN REFRACTORY METASTATIC COLORECTAL CANCER TO EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODIES
    Galal, K.
    Zaghloul, K.
    Mourad, M. A.
    ANNALS OF ONCOLOGY, 2010, 21 : 63 - 63
  • [25] Clinical impact of epidermal growth factor receptor (EGFR) coexpression in early breast cancer with human epidermal growth factor receptor 2 (HER2) overexpression
    Park, S.
    Cho, E.
    Shin, Y.
    Hong, S.
    Lee, M.
    Park, Y.
    Nam, S.
    Yang, J.
    Choi, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [26] The Constitutive Activity of Epidermal Growth Factor Receptor vIII Leads to Activation and Differential Trafficking of Wild-type Epidermal Growth Factor Receptor and erbB2
    Zeineldin, Reema
    Ning, Yan
    Hudson, Laurie G.
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2010, 58 (06) : 529 - 541
  • [27] Human epidermal growth factor receptor-2 expression in primary and metastatic gastric cancer
    Yiting Geng
    Xiaofeng Chen
    Jinrong Qiu
    Yue Zhou
    Jian Wang
    Lingxiang Liu
    Yongfeng Shao
    Yongmei Yin
    International Journal of Clinical Oncology, 2014, 19 : 303 - 311
  • [28] Human epidermal growth factor receptor-2 expression in primary and metastatic gastric cancer
    Geng, Yiting
    Chen, Xiaofeng
    Qiu, Jinrong
    Zhou, Yue
    Wang, Jian
    Liu, Lingxiang
    Shao, Yongfeng
    Yin, Yongmei
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (02) : 303 - 311
  • [29] (-)-epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells
    Shimizu, M
    Deguchi, A
    Lim, JTE
    Moriwaki, H
    Kopelovich, L
    Weinstein, IB
    CLINICAL CANCER RESEARCH, 2005, 11 (07) : 2735 - 2746
  • [30] Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer
    Siena, S.
    Sartore-Bianchi, A.
    Marsoni, S.
    Hurwitz, H. I.
    McCall, S. J.
    Penault-Llorca, F.
    Srock, S.
    Bardelli, A.
    Trusolino, L.
    ANNALS OF ONCOLOGY, 2018, 29 (05) : 1108 - 1119
12345